HealthyDirect · GrowthFit for a long SIP
Groww Short Term Fund
Groww Mutual FundIncome/Debt Oriented Schemes - Short Term Fund13.1 years
The scheme will endeavor to generate stable returns over short term with a low risk strategy while maintaining liquidity through a portfolio comprising of debt and money market instruments.
- NAV
- 2,567.5697
- 29 Oct 2026
- 1Y
- +4.9%
- Trailing CAGR
- AUM
- ₹93.33 Cr
- 30 Sept 2026
- Volatility
- Low
- 1.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Three-year return is above the category median.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Pass
13.1 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.32% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -1.2%. Ask whether you can hold through a similar fall.
Vs category
Fail
33% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Wilfred Peter Gonsalves · 0.5 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 101.0% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+4.9%
- 3Y+7.4%
- 5Y+6.2%
- 10Y+6.5%
- SI+7.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+5.1%
- 3Y+6.6%
- 5Y+6.7%
- 10Y+6.3%
- Since inception
- +7.4%
- Calendar-day CAGR
- Excess 1Y
- +0.6%
- Category median, same plan and option
- 3Y win rate
- +33%
- Windows beating the median
- 3Y percentile
- 75
- Vs comparable share classes
- SIP 3Y XIRR
- +6.6%
- Simulated monthly SIP
- Worst rolling 3Y
- +4.0%
- 2451 daily-ending windows
- Median rolling 3Y
- +7.3%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 1965 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -1.2%
- Worst peak-to-trough
- Current
- 0.0%
- At peak
- Current spell
- 0 days
- Days below latest peak
- Time below peak
- +37%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 5 days
- 272 recovered episodes
- Longest recovery
- 80 days
- Trough to prior peak
31 Mar 2022 – 25 Jul 2022
Trough 6 May 2022 · recovered in 80 days
-1.2%
30 Jul 2019 – 7 Jan 2020
Trough 8 Nov 2019 · recovered in 60 days
-1.2%
9 Mar 2020 – 15 Apr 2020
Trough 19 Mar 2020 · recovered in 27 days
-0.8%
4 Aug 2020 – 1 Sept 2020
Trough 24 Aug 2020 · recovered in 8 days
-0.5%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
75
Vs category
54
Consistency
36
Risk-adjusted
100
Drawdown
97
Mean
72
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 13 holdings · top 10 are 101.0%.
- Top 5
- 71.0%
- Top 10
- 101.0%
- Largest holding
- 32.1%
- Effective holdings
- 6.2
Reverse Repo
Unspecified
32.1%
REC LIMITED SR 257 TR A 7.28 BD 31AG29 FVRS1LAC
Financial
10.1%
LARSEN AND TOUBRO LIMITED 7.725 NCD 28AP28 FVRS1LAC
Industrials
9.7%
EXPORT IMPORT BANK OF INDIA SR AA02 7.35 BD 27JL28 FVRS1LAC
Financial
9.6%
NATIONAL BANK FOR AGRICULTURE AND RURAL DEVELOPMENT SR 26F 7.44 BD 17JL29 FVRS1LAC
Financial
9.6%
What changed
DECISION
Status moved from MONITOR to HEALTHY.
11 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mahindra Manulife Short Term Fund
Mahindra Manulife Mutual Fund
- 1Y
- +4.7%
- 3Y
- +7.5%
- Vol
- 0.9%
- Max DD
- -1.1%
- Sharpe
- 0.60
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher TER
Sundaram Short Term Fund (Formerly Known as Sundaram Short Duration Fund)
Sundaram Mutual Fund
- 1Y
- +4.6%
- 3Y
- +7.3%
- Vol
- 0.9%
- Max DD
- -0.7%
- Sharpe
- 0.78
- 3Y win
- +46%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
Caveat: Lower trailing returns
Axis Short Term Fund
Axis Mutual Fund
- 1Y
- +4.8%
- 3Y
- +7.6%
- Vol
- 1.5%
- Max DD
- -2.6%
- Sharpe
- 1.45
- 3Y win
- +97%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
Bandhan Short Term Fund
Bandhan Mutual Fund
- 1Y
- +5.5%
- 3Y
- +7.6%
- Vol
- 1.4%
- Max DD
- -2.5%
- Sharpe
- 1.28
- 3Y win
- +38%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
BANK OF INDIA SHORT TERM FUND
Bank of India Mutual Fund
- 1Y
- +4.3%
- 3Y
- +7.5%
- Vol
- 6.4%
- Max DD
- -19.8%
- Sharpe
- 0.17
- 3Y win
- +66%
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER